Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025)
Akari Therapeutics recorded quarterly Exchange Rate Effect of -$3000.0 in Q3 2025, down 400.0% quarter-over-quarter from $1000.0 in Q4 2024, and down 250.0% year-over-year from $2000.0 in Q3 2024.
Akari Therapeutics' Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$3000.0 for Q3 2025.
- In Q3 2025, Exchange Rate Effect fell 250.0% year-over-year to -$3000.0; the TTM figure through Sep 2025 stood at -$2000.0 (down 300.0% YoY), while the FY2025 annual figure was $1000.0, up 125.0% from the prior year.
- Exchange Rate Effect came in at -$3000.0 for Q3 2025 at Akari Therapeutics, down from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $30720.0 in Q1 2021 to a low of -$200793.0 in Q4 2021.
- A 5-year average of -$27546.9 and a median of -$3000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect sank 643.44% in 2021 and surged 300.0% in 2024, its largest moves.
- Akari Therapeutics' Exchange Rate Effect stood at -$200793.0 in 2021, then surged by 75.98% to -$48240.0 in 2022, then soared by 112.44% to $6000.0 in 2023, then tumbled by 83.33% to $1000.0 in 2024, then tumbled by 400.0% to -$3000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$3000.0, $1000.0, and $2000.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2022 | -48,240.00 |
| Jun 30, 2022 | -48,240.00 |
| Mar 31, 2022 | -32,350.00 |
| Mar 31, 2022 | -32,350.00 |
| Dec 31, 2021 | -1.55 Bn |
| Dec 31, 2021 | -1.55 Bn |
| Sep 30, 2021 | -27,329.00 |
| Sep 30, 2021 | -27,329.00 |
| Jun 30, 2021 | -78,118.00 |
| Jun 30, 2021 | -78,118.00 |
| Mar 31, 2021 | 30,720.00 |
| Mar 31, 2021 | 30,720.00 |
| Dec 31, 2020 | -221.93 Bn |
| Dec 31, 2020 | -221.93 Bn |
| Sep 30, 2020 | -3,676.00 |
| Sep 30, 2020 | -3,676.00 |
| Jun 30, 2020 | -46,037.00 |
| Jun 30, 2020 | -46,037.00 |
| Mar 31, 2020 | -47.84 Bn |
| Mar 31, 2020 | -47.84 Bn |
| Dec 31, 2019 | 120,738.00 |
| Dec 31, 2019 | 120,738.00 |
| Sep 30, 2019 | 3,281.00 |
| Sep 30, 2019 | 3,281.00 |
| Jun 30, 2019 | -160,116.00 |
| Jun 30, 2019 | -160,116.00 |
| Mar 31, 2019 | 107,168.00 |
| Mar 31, 2019 | 107,168.00 |
| Dec 31, 2018 | -55,943.00 |
| Dec 31, 2018 | -55,943.00 |
| Sep 30, 2018 | -65,848.00 |
| Sep 30, 2018 | -65,848.00 |
| Jun 30, 2018 | -27,188.00 |
| Jun 30, 2018 | -27,188.00 |
| Mar 31, 2018 | 72,713.00 |
| Mar 31, 2018 | 72,713.00 |
| Dec 31, 2017 | 52,153.00 |
| Dec 31, 2017 | 52,153.00 |
| Sep 30, 2017 | 85,428.00 |
| Sep 30, 2017 | 85,428.00 |
| Jun 30, 2017 | 48,577.00 |
| Jun 30, 2017 | 48,577.00 |
| Mar 31, 2017 | -45,153.00 |
| Mar 31, 2017 | -45,153.00 |
| Dec 31, 2016 | 61,116.00 |
| Dec 31, 2016 | 61,116.00 |
| Sep 30, 2016 | -149,340.00 |
| Sep 30, 2016 | -149,340.00 |
| Jun 30, 2016 | -155,409.00 |
| Jun 30, 2016 | -155,409.00 |
| Mar 31, 2016 | -192,944.00 |
| Mar 31, 2016 | -192,944.00 |
| Dec 31, 2015 | -3,709.00 |
| Dec 31, 2015 | -3,709.00 |
| Sep 30, 2015 | -43,262.00 |
| Sep 30, 2015 | -43,262.00 |
| Jun 30, 2015 | 21,219.00 |
| Jun 30, 2015 | 21,219.00 |
| Mar 31, 2015 | -10,328.00 |
| Mar 31, 2015 | -10,328.00 |
| Dec 31, 2014 | 49,641.00 |
| Dec 31, 2014 | 49,641.00 |